Transdermal theranostics

Aung Than; Ping Zan; Peng Chen

doi:10.1002/viw2.21

Transdermal theranostics

Aung Than, Ping Zan, Peng Chen^*

^*Corresponding author for this work

Nanyang Technological University

Research output: Contribution to journal › Review article › peer-review

21 Citations (Scopus)

Abstract

Skin offers an easily accessible site for drug administration as well as for health signal monitoring, with non-invasiveness or minimal-invasiveness, convenience, and good patient compliance. Transdermal theranostics promises for personalized, home-based, and long-term management of chronic diseases, and is expected to change the landscape of healthcare profoundly. In this article, we review the recent advances in transdermal drug delivery, diagnosis based on sweat and skin interstitial fluid, and wearable devices. The advantages, limitations, and commercialization of these emerging techniques are comparatively discussed.

Original language	English
Article number	e21
Journal	VIEW
Volume	1
Issue number	2
DOIs	https://doi.org/10.1002/viw2.21
Publication status	Published - Jun 2020
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2020 The Authors. VIEW published by John Wiley & Sons Australia, Ltd and Shanghai Fuji Technology Consulting Co., Ltd, authorized by Professional Community of Experimental Medicine, National Association of Health Industry and Enterprise Management (PCEM)

ASJC Scopus Subject Areas

Biomaterials
Biomedical Engineering

Access to Document

10.1002/viw2.21

Cite this

@article{7de1eebd772643fbb1cb54c847e8b019,

title = "Transdermal theranostics",

abstract = "Skin offers an easily accessible site for drug administration as well as for health signal monitoring, with non-invasiveness or minimal-invasiveness, convenience, and good patient compliance. Transdermal theranostics promises for personalized, home-based, and long-term management of chronic diseases, and is expected to change the landscape of healthcare profoundly. In this article, we review the recent advances in transdermal drug delivery, diagnosis based on sweat and skin interstitial fluid, and wearable devices. The advantages, limitations, and commercialization of these emerging techniques are comparatively discussed.",

author = "Aung Than and Ping Zan and Peng Chen",

note = "Publisher Copyright: {\textcopyright} 2020 The Authors. VIEW published by John Wiley & Sons Australia, Ltd and Shanghai Fuji Technology Consulting Co., Ltd, authorized by Professional Community of Experimental Medicine, National Association of Health Industry and Enterprise Management (PCEM)",

year = "2020",

month = jun,

doi = "10.1002/viw2.21",

language = "English",

volume = "1",

journal = "VIEW",

issn = "2688-3988",

number = "2",

}

TY - JOUR

T1 - Transdermal theranostics

AU - Than, Aung

AU - Zan, Ping

AU - Chen, Peng

N1 - Publisher Copyright: © 2020 The Authors. VIEW published by John Wiley & Sons Australia, Ltd and Shanghai Fuji Technology Consulting Co., Ltd, authorized by Professional Community of Experimental Medicine, National Association of Health Industry and Enterprise Management (PCEM)

PY - 2020/6

Y1 - 2020/6

N2 - Skin offers an easily accessible site for drug administration as well as for health signal monitoring, with non-invasiveness or minimal-invasiveness, convenience, and good patient compliance. Transdermal theranostics promises for personalized, home-based, and long-term management of chronic diseases, and is expected to change the landscape of healthcare profoundly. In this article, we review the recent advances in transdermal drug delivery, diagnosis based on sweat and skin interstitial fluid, and wearable devices. The advantages, limitations, and commercialization of these emerging techniques are comparatively discussed.

AB - Skin offers an easily accessible site for drug administration as well as for health signal monitoring, with non-invasiveness or minimal-invasiveness, convenience, and good patient compliance. Transdermal theranostics promises for personalized, home-based, and long-term management of chronic diseases, and is expected to change the landscape of healthcare profoundly. In this article, we review the recent advances in transdermal drug delivery, diagnosis based on sweat and skin interstitial fluid, and wearable devices. The advantages, limitations, and commercialization of these emerging techniques are comparatively discussed.

UR - http://www.scopus.com/inward/record.url?scp=85103743762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103743762&partnerID=8YFLogxK

U2 - 10.1002/viw2.21

DO - 10.1002/viw2.21

M3 - Review article

AN - SCOPUS:85103743762

SN - 2688-3988

VL - 1

JO - VIEW

JF - VIEW

IS - 2

M1 - e21

ER -

Transdermal theranostics

Abstract

Bibliographical note

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this